Part, Chapter, Paragraph
1 I, 2. 4 | healthcare interventions (e.g. hypertension detection and treatment,
2 II, 5. 1. 1| role: to give an example, hypertension, smoking habit and excessive
3 II, 5. 1. 1| cholesterol, low HDL cholesterol, hypertension, diabetes and smoking are
4 II, 5. 1. 1| database (htt 7) were : hypertension, hypercholesterol, obesity,
5 II, 5. 1. 1| adopted in risk definition (hypertension and hypercholesterol) and
6 II, 5. 1. 1| End Stage Renal Disease~Hypertension and diabetes, obesity and
7 II, 5. 2. 2| role: to give an example, hypertension, smoking habit and excessive
8 II, 5. 2. 2| cholesterol, low HDL cholesterol, hypertension, diabetes and smoking are
9 II, 5. 2. 2| population level were selected: hypertension, hypercholesterol, obesity,
10 II, 5. 2. 2| adopted in risk definition (hypertension and hypercholesterol) and
11 II, 5. 2. 3| improvement in the control of hypertension; there is evidence suggesting
12 II, 5. 2. 4| important factor, followed by hypertension, obesity, smoking habit,
13 II, 5. 2. 4| recent available data on hypertension prevalence by age range.
14 II, 5. 2. 4| range. It seems clear that hypertension prevalence increases with
15 II, 5. 2. 4| criteria for the definition of hypertension prevalence ( 160 o 95 mmHg;
16 II, 5. 2. 4| Estimated prevalence of hypertension for men and women of different
17 II, 5. 2. 4| risk factor definition (hypertension and hypercholesterolemia)
18 II, 5. 2. 4| factors’ such as smoking, hypertension, hyperlipidemia, diabetes,
19 II, 5. 2. 4| prevalence of patients with hypertension undergoing adequate treatment
20 II, 5. 2. 5| individual risk factors (such as hypertension and hypercholesterolemia)
21 II, 5. 2. 6| pressure and isolated systolic hypertension and the risk of coronary
22 II, 5. 2. 7| Dietary Approaches to Stop Hypertension (DASH) diet. DASH-Sodium
23 II, 5. 4. 1| tends to be associated with hypertension, (high blood pressure) and
24 II, 5. 4. 1| levels (hyperglycaemia), hypertension and the change in lipids
25 II, 5. 6. 3| cardiovascular disease and hypertension; formal education; socio-economic
26 II, 5. 7. 1| chronic diseases such as hypertension, diabetes and cardiovascular
27 II, 5. 7. 3| of dialysis were similar, hypertension and cardiovascular mortality
28 II, 5. 7. 4| 5.7.4. Risk factors~ ~Hypertension and diabetes (Levin 2001),
29 II, 5. 7. 4| true for diseases such as hypertension (Diez Roux et al, 2002)
30 II, 5. 7. 7| clinical practice guidelines on hypertension and antihypertensive agents
31 II, 5. 7. 7| Epidemiology and Prevention. Hypertension 2003;42(5):1050-65.~Seligman
32 II, 5. 8. 3| case of COPD, pulmonary hypertension and consequent heart failure.~•
33 II, 5. 8. 3| allergy, osteoporosis, hypertension, digestive ulcer, articular
34 II, 5. 8. 3| 2005). These were diabetes, hypertension, obesity, stroke, hyper-lipidemia,
35 II, 5. 11. 4| disorders such as angina and hypertension.~ ~High economic costs~Although
36 II, 9 | including pregnancy induced hypertension, preterm labor, caesarean
37 II, 9 | neonatal conditions such as hypertension, pre-eclampsia and fetal
38 II, 9 | and include dyslipidemia, hypertension, diabetes mellitus, cigarette
39 II, 9 | factors, such as dyslipidemia, hypertension, diabetes mellitus, smoking,
40 II, 9 | more closely related to hypertension (which is probably their
41 II, 9. 1. 1| adult illnesses, such as hypertension and diabetes. This life-course
42 II, 9. 1. 2| including pregnancy induced hypertension, preterm labor, caesarean
43 II, 9. 1. 2| neonatal conditions such as hypertension, pre-eclampsia and fetal
44 II, 9. 2. 3| non-insulin-dependent diabetes, hypertension and sleep apnoea, and can
45 II, 9. 2. 3| 1.1 million suffer from hypertension; and 1.2 million suffer
46 II, 9. 2. 3| or more of the following: hypertension, central adiposity, raised
47 II, 9. 3. 1| co-morbidities, such as hypertension and diabetes mellitus, which
48 II, 9. 3. 1| such as obesity, stress and hypertension in diabetic women (European
49 II, 9. 3. 1| levels and treating severe hypertension can reduce the incidence
50 II, 9. 3. 1| 2005). The prevalence of hypertension in Member States appears
51 II, 9. 3. 1| European Commission, 2003). Hypertension is both a disease in itself
52 II, 9. 3. 1| higher risk of developing hypertension, hyperlipidaemia and diabetes
53 II, 9. 3. 1| of co-morbidity, such as hypertension, obesity, metabolic syndrome
54 II, 9. 3. 1| and include dyslipidemia, hypertension, diabetes mellitus, cigarette
55 II, 9. 3. 1| factors, such as dyslipidemia, hypertension, diabetes mellitus, smoking,
56 II, 9. 3. 1| more closely related to hypertension (which is probably their
57 II, 9. 3. 2| fluid embolism, haemorrhage, hypertension, infections/sepsis, obstetrical
58 II, 9. 4. 3| osteoporosis, diabetes, hypertension, incontinence and arthritis.
59 II, 9. 4. 3| than half, through systolic hypertension control (Geriatric Medicine
60 III, 10. 1. 3| Committee on Atherosclerosis and Hypertension in Children, Council on
61 III, 10. 2. 1| cholesterol levels in blood and hypertension (Keil U, et al., 1998).~
62 III, 10. 2. 1| cavity, haemorrhagic stroke, hypertension, pancreatitis and breast
63 III, 10. 2. 1| and increases the risk of hypertension and haemorrhagic stroke
64 III, 10. 2. 1| as type II diabetes and hypertension in adolescents, foretell
65 III, 10. 2. 1| of abdominal obesity with hypertension, dyslipidaemia and impaired
66 III, 10. 6. 2| care interventions (e.g. hypertension detection and treatment,
67 IV, 11. 5. 4| donor age or a history of hypertension and diabetes.~ ~Public awareness
68 IV, 11. 6. 4| burden of illness: diabetes, hypertension, TB, AIDS (84.5% based on
69 IV, 12. 2 | individual risk factors (such as hypertension and hypercholesterolemia)
70 IV, 12. 10 | Intermediate~Regional~ ~Hypertension~High ~National/Regional~ ~
71 IV, 12. 10 | and public health~ ~ ~ ~Hypertension~ ~ ~ ~ ~Interactions amongst
72 IV, 12. 10 | Biowissenschaften, www ~ ~Hypertension~High priority~§ 25 SGB V
73 IV, 12. 10 | e.g. DMP CVD, structured hypertension training~Bloodpressure is
74 IV, 12. 10 | and public health~Low~ ~ ~Hypertension~Intermediate~ ~A campaign
75 IV, 12. 10 | familiarise public with hypertension and the measures for the
76 IV, 12. 10 | prevention and control of hypertension ~ ~ ~ ~NATIONAL HEALTH STRATEGIES
77 IV, 12. 10 | program there are actions for: Hypertension, Obesity, Cholesterol, Cancer,
78 IV, 12. 10 | concerning the bioethics~http ~ ~Hypertension~ high~ ~ During each consultation
79 IV, 12. 10 | Minister on 04.05.2007~ ~Hypertension~ ~Law 138/2004 established
80 IV, 12. 10 | research of human genome~ ~Hypertension~ high~ ~Special target “
81 IV, 12. 10 | under public discussion.~Hypertension~ High~Circular letter on
82 IV, 12. 10 | control of AHT (Arterial Hypertension).~National Programme for
83 IV, 12. 10 | committees is established~Hypertension~ Intermediate~ Law 95/2006
84 IV, 12. 10 | public healh~No indicator~ ~ ~Hypertension~No indicator~ ~Interactions
85 IV, 12. 10 | Intermediate~ At national level~ ~Hypertension~ High~ At national level~
86 IV, 12. 10 | European Guidelines for Hypertension Diagnostics and Therapy /
87 IV, 13. 2. 3| use, 10.9% attributable to hypertension, 7.4% and 7.4% to high cholesterol
88 IV, 13. 2. 3| lower socioeconomic status. Hypertension, unfavourable blood lipid
89 Key, Ap5. 0. 0| hyperlipidaemias~hypersensitivity~hypertension~hypertensive~hypogonadism~
